The company’s device uses ultrasound, which will allow a feeding tube to be placed without need for a surgical setting. With regulatory approval, it’s taking a key step toward commercialization. Baltimore-based medical device startup CoapTech reached a key milestone in April: It can now market its product that allows the placement of a feeding tube without the […]
Baltimore, MD, May 18, 2018 – Paragon Bioservices, Inc. (Paragon), the leading private equity-backed biologics contract development and manufacturing organization (CDMO) with proven expertise in gene therapy and next-generation vaccines, was named the 2018 Life Science Company of the Year by the Maryland Tech Council (MTC). The announcement came at MTC’s 30th Annual Industry Awards held last night […]
During the BioHealth Capital Region Forum held last month, Jim Hughes, Vice President at University of Maryland, Baltimore, was among those interviewed for a BioTalk Podcast including select leaders from different parts of the BioHealth Capital Region discussing what they are working on, and their thoughts on the event. Jim discussed some of the recent startup successes […]
Three common disorders that are on the rise worldwide—attention deficit hyperactivity disorder (ADHD), memory loss, and cardiovascular disease—may be more manageable thanks to a growing area of research and development in “medical foods.” And VAYA Pharma, one of the newest BioPark tenants, is developing medical foods that may hold the key to better management of […]
This fall we had the chance to catch up with Dr. Eddy C. Agbo, who is the Chairman and CEO of Fyodor Biotechnologies. We asked him about his company; see his answers below. Tell us about your company: Fyodor is a socially responsible biotechnology company that addresses urgent global healthcare needs in emerging economies. Fyodor […]
Via Technically Baltimore: AMS, founded in January 2013, has quickly moved to the commercialization stages of its first product, KIDnet, a real-time reporting tool that tracks the outcomes of behavioral health treatment for children and adults.
A year ago, James L. Hughes, M.B.A., vice president and chief enterprise and economic development officer at University of Maryland, Baltimore (UMB), was named director of University of Maryland Ventures (UM Ventures), the ambitious joint research commercialization effort of UMB and University of Maryland, College Park (UMCP), and a central part of the MPowering the State initiative. […]
On April 18, 2013, at 11:30 a.m., Jamie Lacey-Moreira will speak at an MDSG session on “Achieving Consistent PR Messaging.”
PressComm Principal Jamie Lacey-Moreira was on hand along with a large crowd on January 17, 2013, for the “topping out” of the Maryland Proton Treatment Center building.